Free Trial
NYSEAMERICAN:PFNX

Pfenex (PFNX) Stock Price, News & Analysis

Pfenex logo
$12.75 0.00 (0.00%)
As of 10/1/2020

About Pfenex Stock (NYSEAMERICAN:PFNX)

Key Stats

Today's Range
$12.75
$12.75
50-Day Range
$12.75
$12.75
52-Week Range
$5.26
$14.00
Volume
N/A
Average Volume
503,865 shs
Market Capitalization
$437.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PFNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pfenex and its competitors with MarketBeat's FREE daily newsletter.

PFNX Stock News Headlines

NKY Medical Holdings Ltd Class A 300109
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

PFNX Stock Analysis - Frequently Asked Questions

Pfenex's stock was trading at $12.75 on January 1st, 2025. Since then, PFNX shares have increased by 0.0% and is now trading at $12.75.

Pfenex Inc. (NYSEAMERICAN:PFNX) released its quarterly earnings results on Thursday, May, 7th. The biotechnology company reported ($0.31) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.07. The biotechnology company earned $0.68 million during the quarter, compared to the consensus estimate of $3.75 million.

Shares of PFNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pfenex investors own include Inovio Pharmaceuticals (INO), Verastem (VSTM), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX), Bristol Myers Squibb (BMY), Gilead Sciences (GILD) and Ocular Therapeutix (OCUL).

Company Calendar

Last Earnings
5/07/2020
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEAMERICAN:PFNX
Previous Symbol
NYSEMKT:PFNX
CIK
N/A
Fax
N/A
Employees
71
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,297,000
Free Float
N/A
Market Cap
$437.29 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSEAMERICAN:PFNX) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners